1. Sweden Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Enzymatica AB

Enzymatica AB

1.95
SEK
+0.00
(-0.26%)
-0.21EPS
582.56MMarket Cap
Oct 29Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.47
0.68
0.91
0.51
0.6
0.51
0.4
0.72
0.36
0.29
0.29
0.24
0.22
0.19
Basic EPS, GAAP
-0.73
-1.15
-1.33
-0.62
-0.32
-0.41
-0.27
-0.09
-0.29
-0.41
-0.28
-0.28
-0.21
-0.21
Free Cash Flow per Basic Share
-1.03
-1.59
-1.33
-0.73
-0.24
-0.28
-0.25
-0.1
-0.27
-0.41
-0.23
-0.32
-0.17
-0.16
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.81
2.5
0.72
1.4
1.09
1.03
0.77
0.69
0.77
0.71
0.43
0.73
0.51
0.4
Tangible Book Value per Share
0.4
2.05
0.27
0.42
0.15
0.45
0.23
0.18
0.31
0.31
0.05
0.45
0.25
0.14
Basic Weighted Avg Shares
22
28
31
72
98
103
155
155
159
167
178
193
243
243
Sales/Revenue/Turnover
10
19
28
36
59
53
61
111
57
49
51
46
54
45
Operating Margin (%)
-154.53
-171.36
-145.16
-126.57
-50.82
-77.21
-67.95
-10.84
-79.04
-139.37
-94.42
-114.22
-95.3
-113.61
Depreciation Expense
- -
1
1
3
5
6
7
7
7
8
7
6
5
- -
Net Income, GAAP
-16
-32
-41
-45
-31
-43
-41
-13
-45
-69
-50
-53
-52
-52
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-154.52
-169.93
-146.28
-123.36
-52.9
-81.01
-66.84
-11.88
-79.3
-140.27
-97.69
-116.68
-96.27
-114.83
Working Capital
7
51
8
43
15
68
30
18
34
58
6
94
47
32
LT Debt
- -
- -
- -
7
4
3
3
2
1
21
17
1
- -
12
Total Equity
16
62
22
142
111
160
119
107
125
126
77
176
124
98
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-108.83
-82.9
-96.74
-55
-24.95
-31.54
-29.39
-11.71
-39.2
-54.65
-49.02
-42.04
-34.53
-40.52

Capital Structure

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1
1
3
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
12
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
243
243
243
Market Capitalization
461
772
583

Working Capital

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
65
52
36
Cash, Cash Equivalents & STI
33
26
13
Accounts Receivable, Net
10
6
4
Inventories
19
16
14
Total Current Liabilities
18
7
5
Payables & Accruals
- -
- -
- -
ST Debt
1
1
3
Deferred Revenue
- -
- -
- -

Growth Rates

SEK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
61.19%
15.91%
-29.59%
Free Cash Flow
17.96%
42.26%
-32.34%
Net Income, GAAP
21.56%
54.31%
-2.42%
Sales/Revenue/Turnover
12.89%
-10.25%
18.27%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
9
6
13
17
46
2025
12
8
- -
18
54
2026
11
7
- -
- -
- -

Quarterly Earnings Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.1
-0.07
-0.04
-0.05
-0.28
2025
-0.07
-0.06
- -
-0.05
-0.21
2026
-0.06
-0.05
- -
- -
- -

Quarterly Dividends Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Sana Alajmovic
Full Time Employees
20
Sector
Health technology
Industry
Medical specialties
Address
Ideon Science Park Lund SN Sweden 223 70
IPO Date
Jun 14, 2011
Website
enzymatica.se
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
I did not find relevant search results specifically about the recent major changes or detailed company description of Enzymatica AB (publ) (Ticker: ENZY.ST). I will search again focusing specifically on up-to-date details regarding Enzymatica AB's products, services, operations, and recent developments.